A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Pfizer Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 2,239,225 shares of PFE stock, worth $62.7 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,239,225
Previous 2,777,606 19.38%
Holding current value
$62.7 Million
Previous $80 Million 22.3%
% of portfolio
0.22%
Previous 0.31%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$25.89 - $29.73 $13.9 Million - $16 Million
-538,381 Reduced 19.38%
2,239,225 $62.1 Million
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $2.79 Million - $3.62 Million
106,682 Added 3.99%
2,777,606 $80 Million
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $17.6 Million - $20.6 Million
549,885 Added 25.93%
2,670,924 $88.6 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $42 Million - $48.6 Million
-1,163,573 Reduced 35.42%
2,121,039 $77.8 Million
Q1 2023

May 08, 2023

SELL
$39.39 - $51.28 $4.91 Million - $6.39 Million
-124,596 Reduced 3.65%
3,284,612 $134 Million
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $7.17 Million - $9.37 Million
-171,850 Reduced 4.8%
3,409,208 $175 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $25.6 Million - $31.2 Million
584,125 Added 19.49%
3,581,058 $157 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $707,162 - $838,473
-15,198 Reduced 0.5%
2,996,933 $157 Million
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $8.97 Million - $11.1 Million
196,028 Added 6.96%
3,012,131 $156 Million
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $46.6 Million - $69.1 Million
1,128,929 Added 66.91%
2,816,103 $166 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $157,902 - $202,839
-4,023 Reduced 0.24%
1,687,174 $72.6 Million
Q2 2021

Jul 30, 2021

SELL
$35.91 - $40.68 $799,931 - $906,187
-22,276 Reduced 1.3%
1,691,197 $66.2 Million
Q1 2021

May 03, 2021

SELL
$33.49 - $37.77 $240,458 - $271,188
-7,180 Reduced 0.42%
1,713,473 $62.1 Million
Q4 2020

Jan 28, 2021

SELL
$33.47 - $42.56 $10.1 Million - $12.8 Million
-301,494 Reduced 14.91%
1,720,653 $63.3 Million
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $4.48 Million - $5.26 Million
141,238 Added 7.51%
2,022,147 $74.2 Million
Q2 2020

Jul 28, 2020

SELL
$30.12 - $36.54 $984,592 - $1.19 Million
-32,689 Reduced 1.71%
1,880,909 $61.5 Million
Q1 2020

May 06, 2020

BUY
$27.03 - $38.62 $1.79 Million - $2.56 Million
66,249 Added 3.59%
1,913,598 $62.5 Million
Q4 2019

Jan 21, 2020

SELL
$32.92 - $37.36 $1.55 Million - $1.76 Million
-47,217 Reduced 2.49%
1,847,349 $72.4 Million
Q3 2019

Oct 18, 2019

SELL
$32.49 - $42.13 $17.2 Million - $22.3 Million
-528,450 Reduced 21.81%
1,894,566 $68.1 Million
Q2 2019

Jul 30, 2019

BUY
$36.98 - $41.52 $1.89 Million - $2.12 Million
51,105 Added 2.15%
2,423,016 $105 Million
Q1 2019

Apr 29, 2019

SELL
$37.5 - $41.2 $3.89 Million - $4.27 Million
-103,604 Reduced 4.19%
2,371,911 $101 Million
Q4 2018

Jan 25, 2019

SELL
$38.47 - $43.86 $2.97 Million - $3.39 Million
-77,219 Reduced 3.02%
2,475,515 $108 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $3.86 Million - $4.68 Million
-111,998 Reduced 4.2%
2,552,734 $112 Million
Q2 2018

Aug 06, 2018

BUY
$32.98 - $35.16 $830,139 - $885,012
25,171 Added 0.95%
2,664,732 $96.7 Million
Q1 2018

May 03, 2018

BUY
$31.91 - $37.02 $7.67 Million - $8.9 Million
240,455 Added 10.02%
2,639,561 $93.7 Million
Q4 2017

Jan 31, 2018

BUY
$33.26 - $35.29 $2.92 Million - $3.1 Million
87,764 Added 3.8%
2,399,106 $86.9 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $71.7 Million - $78.9 Million
2,311,342
2,311,342 $82.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.